Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for...
NEW STRATEGY NEW TECHNOLOGY : FOTON BRAND REJUVENATION & ALL-NEW PRODUCTS LAUNCH
BEIJING, Oct. 12, 2023 /PRNewswire/ -- On October 11th, FOTON held its global BRAND REJUVENATION & ALL-NEW PRODUCTS LAUNCH event in Changsha, China. 63 Distributors, customers and media representing 22 countries worldwide came together to...
